Search
COMPLEX: Investing in the share market is an inexact science, and biotech stocks can add a further layer of complexity to the formula.

Bitter pill for investors’ pain

Investors scorched by the share price collapse of local pharmaceutical development company pSivida can take some heart from a recent report suggesting they are not alone when it comes to understanding precisely how some drug and biotechnology products actually work.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byECU School of Business and Law

Students

6th-Australian Institute of Management WA20,000
7th-Murdoch University15,536
8th-South Regional TAFE10,549
9th-Central Regional TAFE9,064
10th↑The University of Notre Dame Australia6,720
49 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer